Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Mar 20;34(9):963-71.
doi: 10.1200/JCO.2015.63.5540.

Racial Patterns of Peripheral T-Cell Lymphoma Incidence and Survival in the United States

Affiliations

Racial Patterns of Peripheral T-Cell Lymphoma Incidence and Survival in the United States

Scott V Adams et al. J Clin Oncol. .

Abstract

Purpose: To compare incidence and survival of peripheral T-cell lymphoma (PTCL) subtypes among US racial/ethnic groups.

Methods: Patients with PTCL (age ≥ 15 years; 2000 to 2012) were identified in the Surveillance, Epidemiology, and End Results (SEER) registries. Race/ethnicity was categorized as non-Hispanic white, black, Asian/Pacific Islander, Hispanic white, or American Indian/Alaskan native. Age-standardized annual incidence rates and incidence rate ratios were estimated with 95% CIs, and case-case odds ratios were estimated by race/ethnicity using polytomous regression. Survival was estimated from SEER follow-up data with Cox regression.

Results: Thirteen thousand one hundred seven patients with PTCL were identified. Annual PTCL incidence was highest in blacks and lowest in Native Americans. Compared with non-Hispanic whites, blacks had a higher incidence of PTCL not otherwise specified (PTCL-NOS), anaplastic large-cell lymphoma, and adult T-cell leukemia/lymphoma (ATLL) and a lower incidence of angioimmunoblastic T-cell lymphoma (AITL); Asians/Pacific Islanders had a higher incidence of AITL, extranodal nasal-type natural killer/T-cell lymphoma and NK-cell leukemia (ENKCL), and ATLL and a lower incidence of anaplastic large-cell lymphoma; Hispanics had a higher incidence of AITL and ENKCL; and Native Americans had a lower incidence of PTCL-NOS (all P < .05). The ratio of ENKCL to PCTL-NOS among Native Americans, Asians/Pacific Islanders, and Hispanic whites was approximately three- to four-fold the same ratio among non-Hispanic whites. Survival varied significantly by race/ethnicity (P < .001), with blacks in particular experiencing shorter survival for most subtypes.

Conclusion: Striking variation in incidence, proportions of PTCL subtypes, and survival was observed. Aspects of these PTCL subtype patterns, such as for ENKCL and ATLL, were similar to corresponding global populations. Despite the small population size and limited number of Native American patients, PTCL subtype frequencies in this group were distinct but most similar to Hispanic whites. Survival disparities were evident, especially for blacks compared with non-Hispanic whites.

PubMed Disclaimer

Conflict of interest statement

Authors' disclosures of potential conflicts of interest are found in the article online at www.jco.org. Author contributions are found at the end of this article.

Figures

Fig 1.
Fig 1.
Incidence rate ratios (IRRs) of peripheral T-cell lymphoma (PTCL) subtypes by race/ethnicity compared with non-Hispanic whites (NHWs) in US Surveillance, Epidemiology, and End Results cancer registries (2000 to 2012). IRRs were calculated from age-standardized incidence rates. AI/AN, American Indian/Alaskan native; AITL, angioimmunoblastic T-cell lymphoma; ALCL, anaplastic large-cell lymphoma; A/PI, Asian/Pacific Islander; ATLL, adult T-cell lymphoma/leukemia; ENKCL, extranodal nasal-type natural killer (NK)/T-cell lymphoma and NK-cell leukemia; HW, Hispanic white; ND, not determined because of small numbers; PTCL-NOS, PTCL not otherwise specified.
Fig 2.
Fig 2.
Overall survival of patients with peripheral T-cell lymphoma (PTCL) according to subtype and race/ethnicity, from US Surveillance, Epidemiology, and End Results cancer registries (2000 to 2012). P values are from global log-rank tests of the survival curves. AI/AN, American Indian/Alaskan native; AITL, angioimmunoblastic T-cell lymphoma; ALCL, anaplastic large-cell lymphoma; A/PI, Asian/Pacific Islander; ATLL, adult T-cell lymphoma/leukemia; ENKCL, extranodal nasal-type natural killer (NK)/T-cell lymphoma and NK-cell leukemia; HW, Hispanic white; NHW, non-Hispanic white; PTCL-NOS, PTCL not otherwise specified.

References

    1. Vose J, Armitage J, Weisenburger D. International peripheral T-cell and natural killer/T-cell lymphoma study: Pathology findings and clinical outcomes. J Clin Oncol. 2008;26:4124–4130. - PubMed
    1. Anderson JR, Armitage JO, Weisenburger DD. Epidemiology of the non-Hodgkin’s lymphomas: Distributions of the major subtypes differ by geographic locations—Non-Hodgkin’s Lymphoma Classification Project. Ann Oncol. 1998;9:717–720. - PubMed
    1. Kanno H, Kojya S, Li T, et al. Low frequency of HLA-A*0201 allele in patients with Epstein-Barr virus-positive nasal lymphomas with polymorphic reticulosis morphology. Int J Cancer. 2000;87:195–199. - PubMed
    1. Tajima K, Hinuma Y: Epidemiology of HTLV-I/II in Japan and the world. Gann Monogr Canc Res 39:129-149, 1992.
    1. Morton LM, Wang SS, Devesa SS, et al. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood. 2006;107:265–276. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources